Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center

CANDER, SONER; Dizdar, Oguzhan; ÖZ GÜL, ÖZEN; Guclu, Metin; Unal, Oguz; Tuncel, Ercan; ERTÜRK, ERDİNÇ; Imamoglu, Sazi; ERSOY, CANAN

doi:10.1016/j.pcd.2014.01.010

Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center

Copy For Citation

CANDER S., Dizdar O. S., ÖZ GÜL Ö., Guclu M., Unal O. K., Tuncel E., ...More

PRIMARY CARE DIABETES, vol.8, no.3, pp.256-264, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 8 Issue: 3
Publication Date: 2014
Doi Number: 10.1016/j.pcd.2014.01.010
Journal Name: PRIMARY CARE DIABETES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.256-264
Bursa Uludag University Affiliated: Yes

Abstract

Aim: To compare once- versus twice-daily insulin detemir added on OADS therapy in insulin-naive type 2 diabetes patients in terms of efficacy and safety.